ERBB2 and neoplasm: Nevertheless, analysis of CTCs can capture phenotypic heterogeneity of the tumour of origin, for example in the expression of ER, HER2 and androgen receptors [112,113,114], and also of biological processes driving metastasis such as dynamic changes in epithelial and mesenchymal composition [115,116].